Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
5-HT2A Agonists - Pipeline Insight, 2022
“ 5-HT2A Agonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by p ... Read More
-
DUX4 protein inhibitors - Pipeline Insight, 2022
“ DUX4 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in DUX4 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
GPCR-Targeting Therapies - Epidemiology Forecast - 2032
DelveInsight's "" GPCR-Targeting Therapies - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted GPCR-Targeting Therapies epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), an ... Read More
-
Adeno-Associated Virus Vectors in Gene Therapy - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Adeno-Associated Virus Vectors in Gene Therapy- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Adeno-Associated Virus Vectors in Gene Therapy, historical and forecasted epidemiology as well as the Adeno-Associated Virus V ... Read More
-
Adeno-Associated Virus (AAV) Vectors in Gene Therapy - Epidemiology Insight - 2032
DelveInsight's "" Adeno-Associated Virus (AAV) Vectors in Gene Therapy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Adeno-Associated Virus (AAV) Vectors in Gene Therapy epidemiology in the 7MM, i.e., the United States, EU5 (Ge ... Read More
-
Gene Therapies for Cardiomyopathies - Epidemiology Forecast - 2032
DelveInsight's "" Gene Therapies for Cardiomyopathies - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene Therapies for Cardiomyopathies epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and t ... Read More
-
CRISPR Therapies - Epidemiology Forecast - 2032
DelveInsight's "" CRISPR Therapies - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CRISPR Therapies epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geograp ... Read More
-
Gene therapy for ocular rare disease Market Insights, Competitive Landscape and Market Forecast–2026
Gene therapy for ocular rare disease Market Insights, Competitive Landscape and Market Forecast–2026 ‘Gene therapy for ocular rare disease - Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Gene therapy for ocular rare disease and the hi ... Read More
-
Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032
DelveInsight's "" Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Graft Versus Host Disease (GvHD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Uni ... Read More
-
Interferon - Biosimilar Insight, 2022
DelveInsight’s, “ Interferon– Biosimilar 2022 ,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipeline drugs in Interferon Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More
-
Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022
“ Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Ubiquitin conjugating enzyme Inhibitor development. The report provides detailed coverage of ... Read More
-
WEE1 protein inhibitors - Pipeline Insight, 2022
“ WEE1 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in WEE1 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2022
“ Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
-
MPYS protein stimulants - Pipeline Insight, 2022
“ MPYS protein stimulants - Pipeline Insight, 2022 ” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in MPYS protein stimulants pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeuti ... Read More
-
Stem Cell Mobilization - Epidemiology Forecast - 2032
DelveInsight's "" Stem Cell Mobilization - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Stem Cell Mobilization epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Ja ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
DelveInsight’s, “ Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022 ,” report provides an understanding of the current competition, pipeline products, and changing market dynamics of the Liquid Biopsy for Cancer Diagnostics market in the 7 major pharmaceutical ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast - 2032
DelveInsight's "" CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) epidemiology in the 7MM, i.e., the United State ... Read More
-
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Forecast - 2032
DelveInsight's "" Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Chimeric Antigen Receptor (CAR) T-Cell Therapy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022
“ Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detaile ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
“ HIV integrase inhibitors - Pipeline Insight, 2021 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in HIV integrase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeut ... Read More
-
Gene therapy in rare diseases - Epidemiology Forecast - 2032
DelveInsight's "" Gene therapy in rare diseases - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene therapy in rare diseases epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032
DelveInsight's "" 22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted 22q11.2 Deletion Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More
-
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
DelveInsight's "" Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barre Syndrome (GBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
DelveInsight's "" Cytokine Release Syndrome (CRS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cytokine Release Syndrome (CRS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
Research Assistance
